• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » AdvaMed: More is better when it comes to DTC marketing

AdvaMed: More is better when it comes to DTC marketing

March 5, 2009 By MassDevice staff

Looking to head consumer advocates, regulators and members of Congress off at the pass, the Advanced Medical Technology Association came up with a set of guidelines for medical device makers’ direct-to-consumer marketing campaigns.

The issue has attracted the attention of consumer advocates after high-profile marketing campaigns by Johnson & Johnson and Biomet featuring Duke University basketball coach Mike Krzyzewski and former Olympic gymnast Mary Lou Retton.

“We see a lot of value in direct-to-consumer advertising, but you have to make sure that the information is useful and accurate,” AdvaMed president and CEO Steve Ubl told the Reuters news service.

Although federal Food and Drug Administration currently regulates promotional materials for devices by ensuring that they include information about possible risks, and the Federal Trade Commission oversees advertisements for smaller devices such as bandages and other over-the-counter products, consumer groups are pushing for stricter limits.

DTC marketing of medical devices has also attracted attention on Capital Hill, where Sen. Herb Kohl convened hearings on the practice last fall. The Wisconsin Democrat said he is concerned that the advertising might under-emphasize the risk of complications associated with implanted medical devices.

In an effort to forestall legislative action, AdvaMed issued guidelines for medical device manufacturers to sue in their DTC campaigns.

The ads should not minimize risk information, according to the guidelines, and device companies should make sure physicians know all the risks and benefits associated with a product before embarking on a DTC campaign.

“I will be paying close attention to how individual companies implement AdvaMed’s strengthened policies to ensure that consumers’ interests are protected,” Kohl told The Associated Press.

Filed Under: Business/Financial News Tagged With: Direct-to-Consumer

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy